OXEA is a global leader in oxo products. Today, we employ more than 1,200 people worldwide at our plants in Germany, the USA and China. We know the market and the needs of our customers. This has earned us a reputation as an expert and reliable partner and supplier that is equipped to deal with all kinds of market situations.
OXEA was formed in 2007 by a merger of European Oxo – a joint venture of Celanese and Degussa (now Evonik) – and selected business units of Celanese Chemicals.
In the years that followed, the company grew and expanded its presence in both existing and new markets.
The discovery of hydroformylation (also known as oxo synthesis) – a process developed by Otto Roelen at the Ruhrchemie plant, the companies’ largest production site in Oberhausen – was a major milestone for the industry and one that helped propel the company to the forefront of the global market.
In 2014, the company significantly strengthened its market position with its first Asian production site in Nanjing, China.
From 2013 to 2025, the company was part of OQ, an integrated energy company with roots in Oman. In 2020, OXEA was renamed OQ Chemicals.
Since 2025 the company is part of the portfolio of Strategic Value Partners (SVP) and Blantyre and has been known as OXEA again.